Vicarious Surgical (RBOT) Interest Expenses (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Interest Expenses came in at $17.0 million in Q3 2025, up 577.7% year-on-year from $2.5 million in Q3 2024, and up 558.74% on a QoQ basis from $2.6 million in Q2 2025.
Vicarious Surgical (RBOT) Interest Expenses (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Interest Expenses data on file, last reported at $17.0 million in Q3 2025.
- On a quarterly basis, Interest Expenses rose 577.7% year-over-year to $17.0 million in Q3 2025; TTM through Dec 2025 was $1.7 million, a 3876.74% increase from a year earlier, with the FY2024 full-year figure at $90.4 million, up 24.08% from the prior year.
- Interest Expenses for Q3 2025 stood at $17.0 million, up from $2.6 million in the prior quarter.
- Over the last five years, Interest Expenses for RBOT reached as high as $17.0 million in Q3 2025 and fell as low as -$1.6 million in Q4 2023.
- Historically, Interest Expenses has averaged $2.9 million across 5 years, with a median of $558000.0 in 2024.
- Across the five-year window, Interest Expenses jumped 25500.0% in 2022 and plunged 544.79% in 2023, its largest moves.
- Year by year, Interest Expenses stood at $13000.0 in 2021, then surged by 2630.77% to $355000.0 in 2022, then plunged by 544.79% to -$1.6 million in 2023, then surged by 136.48% to $576000.0 in 2024, then surged by 2843.75% to $17.0 million in 2025.
- Per Business Quant data, the three most recent Interest Expenses figures were $17.0 million in Q3 2025, $2.6 million in Q2 2025, and $576000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 16.96 Mn |
| Sep 30, 2025 | 16.96 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Mar 31, 2025 | 576,000.00 |
| Mar 31, 2025 | 576,000.00 |
| Dec 31, 2024 | 576,000.00 |
| Dec 31, 2024 | 576,000.00 |
| Sep 30, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 8.86 Mn |
| Jun 30, 2024 | 8.86 Mn |
| Mar 31, 2024 | 558,000.00 |
| Mar 31, 2024 | 558,000.00 |
| Dec 31, 2023 | -1.58 Mn |
| Dec 31, 2023 | -1.58 Mn |
| Sep 30, 2023 | 6.50 Mn |
| Sep 30, 2023 | 6.50 Mn |
| Jun 30, 2023 | 15.30 Mn |
| Jun 30, 2023 | 15.30 Mn |